Home > News > Nano-Particle Cancer Therapeutic for NCI-sponsored Clinical Trial
September 12th, 2005
Nano-Particle Cancer Therapeutic for NCI-sponsored Clinical Trial
Abstract:
CytImmune Sciences, Inc., a clinical stage nano-biotechnology company focused on the delivery of therapeutics, today announced that it would enter into production of its first tumor-targeting biotherapeutic for an upcoming clinical trial sponsored by the National Cancer Institute.
Source:
pharmalive.com
Related News Press |
Possible Futures
Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024
Nanomedicine
High-tech 'paint' could spare patients repeated surgeries March 8th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
Announcements
What heat can tell us about battery chemistry: using the Peltier effect to study lithium-ion cells March 8th, 2024
Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||